Anatomic Pathology Market Regional Analysis

Globally, North America dominated the anatomic pathology market and accounted for the largest market share in 2021 and its set to continue this dominance throughout the forecast period. Increasing implementation of digital pathology, early adoption of advanced imaging tools, and rising consumer awareness regarding regular health screening are the few major factors likely to drive the growth of the market in the region over the coming years. In addition, presence of many well-known market players such as Pfizer Inc., Johnson & Johnson Pvt Ltd., and Abbott Laboratories in the region is also propelling the growth of the anatomic pathology market.

Furthermore, Asia Pacific region is witnessing a significant growth rate during the forecast period. The growing geriatric population, increasing adoption of highly advanced technology mainly in developing countries such as India, China, and Indonesia, and rising consumer disposable income are the major factors likely to boost the growth of the market in the region over the next coming years. In addition, increasing development of healthcare infrastructure in the region by the construction of highly advanced hospitals is also anticipated to impact the demand for anatomic pathology positively.